SiPhox
Burlington, United States · $32.0M raised
- Headquarters
- Burlington, Massachusetts
- Employees
- 11–50
- Business Model
- B2C
- Website
- siphox.com
- Total Funding
- $32.0M
- Last Round
- $5.0M Series AMar 2025
- Rounds
- 3
About
SiPhox Health offers comprehensive at-home blood testing, enabling individuals to measure biomarkers for disease risk assessment and healthspan optimization without lab visits or appointments. The platform provides data-driven health insights and coaching. It has served over 50,000 customers seeking convenient, affordable blood diagnostics.
Summary
SiPhox is a Healthcare company based in Burlington, United States. It has raised $32.0M in total across 3 rounds, most recently a $5.0M Series A round in Mar 2025. Investors include LongeVC, Khosla Ventures and Y Combinator Continuity Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe